Latest News of BCEL
AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates
By Yahoo! Finance |
2 weeks ago
AbCellera Biologics Inc. disappointed analysts with lower-than-expected quarterly results. Analysts have revised forecasts, predicting a 37% revenue increase in 2025. Despite concerns, price targets v...
AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript
By Yahoo! Finance |
2 weeks ago
AbCellera provided updates on their pipeline progress and financials, emphasizing their transition to a clinical stage biotech company. They anticipate CTA filings for two programs in Q2 next year. Th...
AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025?
By Yahoo! Finance |
2 months ago
A list of the top multibagger penny stocks for 2025 was compiled, with AbCellera Biologics Inc. being a standout. The term multibagger refers to stocks that can increase substantially....